John Katsaras

Distinguished R&D Staff

John graduated with a PhD in Biophysics from the University of Guelph (ON, Canada) in 1991 under the supervision of R.H. Stinson. He then went on to post doctoral studies with R.H. Stinson and J.H. Davis (U of Guelph, ON, Canada), R.M. Epand (McMaster University, Hamilton, ON, Canada) and  J. Dufourcq (Centre National de la Recherche Scientifique, Pessac, France). In 1994, John returned to Canada to work at the Chalk River Laboratories (Chalk River, ON, Canada). In 1997 the neutron scattering group, which John was a member of, was transferred to the National Research Council (NRC) of Canada. The group remained located at Chalk River with access to the National Research Universal (NRU) reactor. In the fall of 2010 John joined ORNL's Neutron Sciences Directorate.

Awards

HONORS / AWARDS  
NRC/Steacie Institute for Molecular Sciences: Annual Award for Improving Life in the Institute, Canada (2007)  
NRC/Steacie Institute for Molecular Sciences: Outstanding Achievement Award, Canada (2001)  
NRC/Steacie Institute for Molecular Sciences: Outstanding Achievement Award, Canada (1999)
Centre National de la Recherche Scientifique (CNRS), Poste Rouge Fellowship, France (1993 - 94)
Natural Sciences and Engineering Research Council of Canada, Post-doctoral Fellowship, Canada (1992 – 94)  
Ontario Graduate Scholarship, Ontario Ministry of Training, Colleges and Universities, ON, Canada (1987 – 88; 1989 – 90)  
Physical Sciences Graduate Scholarship, College of Physical and Engineering Science, University of Guelph, ON, Canada (1986 – 87; 1988 – 89)

Facilities

Spallation Neutron SourceHigh Flux Isotope Reactor

Patents

PATENTS / AGREEMENTS  Patent – NRC/Cincinnati Children’s Hospital. “Spontaneously Forming Ellipsoidal Phospholipid Unilamellar Vesicles”. X. Qi, M.-P. Nieh and J. Katsaras; US Provisional Patent No. 60/862,321 (October 20, 2006); US Patent No. 11/741,323 (April 27, 2007); World International Property Organization No. WO 2008/051818 A2 (May 2, 2008)  Provisional Patent 12078-1 – NRC. “Single Domain Antibody-Targeted Carrier for Contrast Agents and Drug Delivery Agents”. A. Abulrob, D. Stanimirovic, U. Iqbal, M.-P. Nieh and J. Katsaras International PCT Application PCT/CA2009/001729 entitled “Antibody-Targeted Carrier for Contrast Agents” has entered the National Phase in Canada on May 18, 2011.  International PCT Application PCT/CA2009/001729 entitled “Antibody-Targeted Carrier for Contrast Agents” has entered the National Phase in the United States on May 20, 2011 and has been allotted United States. Patent Application No. 13/130,339.  International PCT Application PCT/CA2009/001729 entitled “Antibody-Targeted Carrier for Contrast Agents” entered the National Phase in Europe on June 22, 2011.  Memorandum of Understanding – NRC/MDS-Nordion. “Targeted Molecular Imaging”. November 7, 2008  Agreement for R&D Collaboration – NRC/McGill. “Development and Evaluation of Dopamine Receptor – Targeting Radiopharmaceutical Formulations and Improved Blood-Brain Barrier Permeability”. 2008 – 2009  Memorandum of Understanding – UT-Battelle, LLC/NRC. “Collaborative Opportunities Involving Neutron Scattering”. June, 2012

Publications